Skip to main content
. 2014 Oct 14;20(1):50–56. doi: 10.1016/j.rpor.2014.09.003

Table 1.

Stage and pathologic characteristics of all patients.

N (%)
FIGO stage
I 175 (67%)
II 47 (18%)
III 39 (15%)
Histological type
Endometrioid adenocarcinoma 195 (74.7%)
Papillary – serous 19 (7.3%)
Clear-cell 10 (3.8%)
Other 37 (14.2%)
Pathological grade
I 104 (39.8%)
II 108 (41.4%)
III 49 (18.8%)
Tumour size (cm)
≤2 cm 224 (85%)
>2 cm 37 (14.2%)
Myometrial invasion
No invasion 21 (8%)
>50% 112 (43%)
<50% 128 (49%)